Apexigen
San Carlos
About Apexigen
Apexigen is a clinical-stage biopharmaceutical company developing antibody therapeutics for the treatment of cancer. It specializes in new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $175.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2023)
- Ticker: nasdaq:APGN
- Website: apexigen.com
- Phone: 650 931-6235
Industries & Categories
Biopharma, Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/apexigen-6699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.